Also published in Send Press Releases with GlobeNewswire:
Novateur Ventures Explores New Strategy to Reduce Hyperinflammatory Response Caused by COVID-19
x hide permanently

GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

Send Press Releases with GlobeNewswire


Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness, and serious disease confirms that the Company’s Director of Clinical Affairs & Medical Education, Erika Spaeth, Ph.D. will be presenting at 2021 San Antonio Breast Cancer Symposium.

  • New geneType Breast Cancer Test showed improved discrimination and calibration over traditional clinical models
  • Study included over 200,000 participants to validate the risk model with an expanded panel of 313 SNPs
  • Poster Presentation highlights the ongoing development of geneType Breast Cancer Risk Test
  • GeneType for Breast Cancer can identify risk ...